MEDPHAR
ActiveSummary
MEDPHAR has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €66k and a net result of €2k. Equity is growing by ~33.9% per year across the filed fiscal years. Its solvency ranks better than 43% of 18400 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability70▼-13
Solvency51▲+1
Growth78=
Track record100
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity tight (current ratio 1.11 against 1.08 in 2024; short-term debt: 54.4% and cash: 3.2% of total assets), and 74.4% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
25.6%
Return on assets
0.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
61 d late
2023
29 d late
2022
72 d late
2021
92 d late
2020
31 d late
2018
14 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€66k▲ 3.7%
2024 · €63k
Total assets
€256k▼ 0.6%
2024 · €257k
Net result
€2k▼ 91.8%
2024 · €28k
Working capital
€16k▲ 52.0%
2024 · €10k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€31k€4k▼ 88.0%€20k▲ 443%€35k▲ 71.7%€9k▼ 74.4%
Net result€29k€-53€12k€28k▲ 141%€2k▼ 91.8%
Equity€23k€23k▼ 0.2%€35k▲ 51.3%€63k▲ 81.9%€66k▲ 3.7%
Total assets€275k▼ 9.8%€302k▲ 9.8%€239k▼ 20.9%€257k▲ 7.8%€256k▼ 0.6%
Debt€252k▼ 19.0%€279k▲ 10.7%€204k▼ 26.9%€194k▼ 4.8%€190k▼ 2.0%
Working capital€-75k▼ 0.4%€-22k▲ 70.4%€3k€10k▲ 287%€16k▲ 52.0%
Staff (FTE)1=
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 74% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €256k
Fixed assets
€101k ▼ 17.8%
Current assets
€155k ▲ 15.1%
Equity and liabilities €256k
Equity
€66k ▲ 3.7%
Debt
€190k ▼ 2.0%
Debt's share of the balance-sheet total falls from 75.4% to 74.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€34k▼
2024 · €59k
Cash flow
€27k▼
2024 · €53k
Current ratio
1.11▲
2024 · 1.08
Quick ratio
0.73▲
2024 · 0.64
Debt to equity
2.90▼
2024 · 3.07
ROE
3.5%▼
2024 · 45.0%
ROA
0.9%▼
2024 · 11.1%
Interest coverage
6.01▼
2024 · 9.40
Debt ≤ 1 year
€139k▲
2024 · €124k
Debt > 1 year
€51k▼
2024 · €70k
Income taxes
€932
Staff costs
€78k▲
2024 · €55k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €2k | - | - | - | - | - |
| Remuneration, social security and pensions62 | €78k | €77k | €99k | €55k | €78k | ▲ 43.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €34k | €38k | €31k | €25k | €25k | ▲ 1.0% |
| Other operating charges640/8 | €1k | €3k | €3k | €2k | €2k | ▼ 8.9% |
| Gross operating margin9900 | €144k | €122k | €153k | €116k | €114k | ▼ 1.8% |
| Operating profit (loss)9901 | €31k | €4k | €20k | €35k | €9k | ▼ 74.4% |
| Financial income75/76B | €16 | €0 | €2 | €31 | €0 | ▼ 100.0% |
| Recurring financial income75 | €16 | €0 | €2 | €31 | €0 | ▼ 100.0% |
| Financial charges65/66B | €3k | €4k | €8k | €6k | €6k | ▼ 11.1% |
| Recurring financial charges65 | €3k | €4k | €8k | €6k | €6k | ▼ 11.1% |
| Profit (loss) for the period before taxes9903 | €28k | €-53 | €12k | €28k | €3k | ▼ 88.6% |
| Income taxes67/77 | €-962 | - | - | - | €932 | - |
| Profit (loss) for the period9904 | €29k | €-53 | €12k | €28k | €2k | ▼ 91.8% |
| Profit (loss) for the period to be appropriated9905 | €29k | €-53 | €12k | €28k | €2k | ▼ 91.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €275k | €302k | €239k | €257k | €256k | ▼ 0.6% |
| Fixed assets21/28 | €171k | €138k | €109k | €122k | €101k | ▼ 17.8% |
| Tangible fixed assets22/27 | €170k | €137k | €107k | €121k | €99k | ▼ 18.0% |
| Land and buildings22 | €25k | €24k | €23k | €22k | €21k | ▼ 4.6% |
| Plant, machinery and equipment23 | €16k | €12k | €7k | €24k | €23k | ▼ 3.5% |
| Furniture and vehicles24 | €74k | €63k | €45k | €45k | €26k | ▼ 41.4% |
| Other tangible fixed assets26 | €54k | €38k | €32k | €31k | €29k | ▼ 4.3% |
| Financial fixed assets28 | €1k | €1k | €1k | €1k | €1k | = |
| Current assets29/58 | €104k | €164k | €130k | €135k | €155k | ▲ 15.1% |
| Stocks and contracts in progress3 | €36k | €54k | €48k | €56k | €53k | ▼ 4.5% |
| Stocks30/36 | €36k | €54k | €48k | €56k | €53k | ▼ 4.5% |
| Amounts receivable within one year40/41 | €35k | €108k | €72k | €74k | €94k | ▲ 27.1% |
| Trade receivables40 | €26k | €90k | €69k | €74k | €94k | ▲ 27.1% |
| Other amounts receivable41 | €9k | €18k | €3k | - | - | - |
| Cash at bank and in hand54/58 | €33k | €1k | €8k | €5k | €8k | ▲ 57.2% |
| Deferred charges and accrued income490/1 | - | €379 | €2k | €524 | €388 | ▼ 25.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €275k | €302k | €239k | €257k | €256k | ▼ 0.6% |
| Equity10/15 | €23k | €23k | €35k | €63k | €66k | ▲ 3.7% |
| Contributions10/11 | €16k | €16k | €16k | €16k | €16k | = |
| Reserves13 | €2k | €2k | €2k | €2k | €4k | ▲ 125% |
| Non-distributable reserves130/1 | €2k | €2k | €2k | €2k | €2k | = |
| Reserves not available under the articles1311 | €2k | €2k | €2k | €2k | €2k | = |
| Distributable reserves133 | - | - | - | - | €2k | - |
| Profit (loss) carried forward14 | €5k | €5k | €17k | €45k | €45k | = |
| Amounts payable17/49 | €252k | €279k | €204k | €194k | €190k | ▼ 2.0% |
| Amounts payable after more than one year17 | €73k | €93k | €77k | €70k | €51k | ▼ 26.7% |
| Financial debts170/4 | €73k | €93k | €77k | €70k | €51k | ▼ 26.7% |
| Amounts payable within one year42/48 | €179k | €186k | €127k | €124k | €139k | ▲ 11.9% |
| Current portion of amounts payable after more than one year42 | €14k | €23k | €46k | €45k | €47k | ▲ 2.9% |
| Financial debts43 | €50k | €50k | - | - | - | - |
| Credit institutions430/8 | €50k | €50k | - | - | - | - |
| Trade debts44 | €71k | €100k | €57k | €56k | €64k | ▲ 15.3% |
| Suppliers440/4 | €71k | €100k | €57k | €56k | €64k | ▲ 15.3% |
| Taxes, remuneration and social security45 | €44k | €13k | €24k | €24k | €29k | ▲ 21.2% |
| Taxes450/3 | €12k | €4k | €11k | €5k | €6k | ▲ 33.4% |
| Remuneration and social security454/9 | €32k | €9k | €13k | €19k | €23k | ▲ 18.2% |
| Other amounts payable47/48 | - | - | €63 | €63 | €88 | ▲ 39.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €29k | €-53 | €12k | €28k | €2k | ▼ 91.8% |
| + Depreciation and write-downs630 | €34k | €38k | €31k | €25k | €25k | ▲ 1.0% |
| Operating cash flow (approximation) | €63k | €38k | €43k | €53k | €27k | ▼ 48.7% |
| Investment in fixed assets (approximation) | - | €-5k | €-2k | €-39k | €-3k | ▲ 91.8% |
| Change in cash | - | €-31k | €6k | €-2k | €3k | ▲ 223% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
31-12
Financial
Back to profitnet €12k
Net result €12k after one loss-making year.
11-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 72 days late
2022
31-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 92 days late
2021
31-12
Financial
Back to profitnet €29k
Net result €29k after 2 loss-making years.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Weakest financial yearnet €-27k
Net result drops to €-27k, the lowest in the series; recovery starts the following year.
2019
17-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
23-10
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 84 days late
2017
28-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
25-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2002
Ground area
57 m²
Building footprint
57 m²
Volume, LiDAR
799 m³
Parcel 21910E0195/00V006, Brussels · tallest building 16.5 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
PHARMACIE MEDPHAR
since 20022.115.080.446
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21910E0195/00V006 | Brussels | 57 m² | 1 · 57 m² | 16.5 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE GONAY
BE 0894.414.729
Liège · Eq €65,535
APOTHEEK LINDENBOS
BE 0829.498.369
Aartselaar · Eq €65,527
APOTHEEK HEINDRYCKX
BE 0467.180.209
Gent · Eq €65,583
SIRRAH
BE 0441.549.641
Tournai · Eq €65,393
POELMAN
BE 0428.334.479
Tessenderlo-Ham · Eq €65,390
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 3,059 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded08-08-2002
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.